Macfarlanes advises AIM-traded eyewear provider Inspecs on recommended takeover

"Macfarlanes advised Inspecs, the AIM-traded provider of eyewear solutions, on a competitive takeover process. Inspecs reached agreement on the terms of a recommended cash acquisition (with an unlisted securities alternative) by a consortium owned by Luke Johnson and Ian Livingstone after having held discussions with three separate bidders."

Macfarlanes represented Inspecs, the AIM-traded provider of eyewear solutions, in a competitive takeover process and related advisory matters. Inspecs and the bidding consortium announced they had reached agreement on the terms of a recommended cash acquisition of Inspecs, with an unlisted securities alternative. The consortium acquisition vehicle is owned by entrepreneur and investor Luke Johnson and property investor and former Optika Clulow chairman Ian Livingstone. Inspecs had previously disclosed that it was in discussions with three separate bidders following unsolicited approaches. Macfarlanes worked closely with Inspecs’ Transaction Committee in relation to the transaction. Macfarlanes represented Inspecs with a team composed by: Harry Coghill (partner, corporate M&A); Mark Slade (senior counsel, corporate M&A); Rhian Edwards (associate, corporate M&A); Malcolm Walton (partner, competition); Matthew Jones (senior associate, competition); Uwen Yap (associate, competition); Rasmus Berglund (partner, share incentives); Clio Pialorsi (associate, share incentives); Jeremy Moncrieff (partner, tax); and Bezhan Salehy (senior associate, tax). Inspecs' Transaction Committee comprised Christopher Hancock and Shaun Smith.

Macfarlanes advises AIM-traded eyewear provider Inspecs on recommended takeover

Read the full story

Cookie Preferences

Strictly Necessary

Analytics & Statistics

Marketing & Ads